Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 310

1.

Acetylation of non-histone proteins modulates cellular signalling at multiple levels.

Spange S, Wagner T, Heinzel T, Krämer OH.

Int J Biochem Cell Biol. 2009 Jan;41(1):185-98. doi: 10.1016/j.biocel.2008.08.027. Epub 2008 Sep 2. Review.

PMID:
18804549
2.

Histone acetylation in gene regulation.

Verdone L, Agricola E, Caserta M, Di Mauro E.

Brief Funct Genomic Proteomic. 2006 Sep;5(3):209-21. Epub 2006 Jul 28. Review.

PMID:
16877467
3.

Reversible acetylation of non histone proteins: role in cellular function and disease.

Batta K, Das C, Gadad S, Shandilya J, Kundu TK.

Subcell Biochem. 2007;41:193-212. Review.

PMID:
17484129
4.

Acetylation of Sirt2 by p300 attenuates its deacetylase activity.

Han Y, Jin YH, Kim YJ, Kang BY, Choi HJ, Kim DW, Yeo CY, Lee KY.

Biochem Biophys Res Commun. 2008 Oct 31;375(4):576-80. doi: 10.1016/j.bbrc.2008.08.042. Epub 2008 Aug 21.

PMID:
18722353
5.
6.
7.

Acetylation of proteins as novel target for antitumor therapy: review article.

Di Gennaro E, Bruzzese F, Caraglia M, Abruzzese A, Budillon A.

Amino Acids. 2004 Jul;26(4):435-41. Epub 2004 Jun 11. Review.

PMID:
15290351
8.

HDACi--targets beyond chromatin.

Buchwald M, Krämer OH, Heinzel T.

Cancer Lett. 2009 Aug 8;280(2):160-7. doi: 10.1016/j.canlet.2009.02.028. Epub 2009 Apr 1. Review.

PMID:
19342155
9.

A pervasive role of histone acetyltransferases and deacetylases in an NF-kappaB-signaling code.

Calao M, Burny A, Quivy V, Dekoninck A, Van Lint C.

Trends Biochem Sci. 2008 Jul;33(7):339-49. doi: 10.1016/j.tibs.2008.04.015. Epub 2008 Jun 26. Review.

PMID:
18585916
10.

Site-specific acetylation of p53 directs selective transcription complex assembly.

Roy S, Tenniswood M.

J Biol Chem. 2007 Feb 16;282(7):4765-71. Epub 2006 Nov 22.

11.

Regulation of protein turnover by acetyltransferases and deacetylases.

Sadoul K, Boyault C, Pabion M, Khochbin S.

Biochimie. 2008 Feb;90(2):306-12. Epub 2007 Jul 1. Review.

PMID:
17681659
12.

Histone deacetylases: complex transducers of nuclear signals.

Johnson CA, Turner BM.

Semin Cell Dev Biol. 1999 Apr;10(2):179-88. Review.

PMID:
10441071
13.

Remodeling chromatin and stress resistance in the central nervous system: histone deacetylase inhibitors as novel and broadly effective neuroprotective agents.

Langley B, Gensert JM, Beal MF, Ratan RR.

Curr Drug Targets CNS Neurol Disord. 2005 Feb;4(1):41-50. Review.

PMID:
15723612
14.

The role of histone deacetylases (HDACs) in human cancer.

Ropero S, Esteller M.

Mol Oncol. 2007 Jun;1(1):19-25. doi: 10.1016/j.molonc.2007.01.001. Epub 2007 Mar 7. Review.

15.
16.

Acetylation of nuclear receptors in cellular growth and apoptosis.

Fu M, Wang C, Zhang X, Pestell RG.

Biochem Pharmacol. 2004 Sep 15;68(6):1199-208. Review.

PMID:
15313417
17.

Targeted histone deacetylase inhibition for cancer therapy.

Vigushin DM, Coombes RC.

Curr Cancer Drug Targets. 2004 Mar;4(2):205-18. Review.

PMID:
15032670
18.

[Assay for inhibitory activity of histone deacetylase].

Yoshida M.

Gan To Kagaku Ryoho. 2004 Apr;31(4):507-11. Japanese.

PMID:
15114691
19.

Regulation of NF-kappaB action by reversible acetylation.

Greene WC, Chen LF.

Novartis Found Symp. 2004;259:208-17; discussion 218-25. Review.

PMID:
15171256
20.

Epi-drugs to fight cancer: from chemistry to cancer treatment, the road ahead.

Mai A, Altucci L.

Int J Biochem Cell Biol. 2009 Jan;41(1):199-213. doi: 10.1016/j.biocel.2008.08.020. Epub 2008 Aug 22. Review.

PMID:
18790076

Supplemental Content

Support Center